Updated July 31 at 5:31pm

Butler Hospital launches innovative Alzheimer’s study

PROVIDENCE – Butler Hospital is the first of 60 clinical trial sites in the U.S. to begin administering an investigational drug to test a new way to prevent the memory loss associated with Alzheimer’s disease in adults who may be at higher risk for developing the disease, but who have no symptoms. Butler is actively seeking volunteers in this age range who have normal memory function.

To continue reading this article, please do one of the following.



Enter your email to receive Providence Business News' e-newsletters
and breaking news alerts.  

health care

Butler Hospital launches innovative Alzheimer’s study

Posted:

PROVIDENCE – Butler Hospital is the first of 60 clinical trial sites in the U.S. to begin administering an investigational drug to test a new way to prevent the memory loss associated with Alzheimer’s disease in adults who may be at higher risk for developing the disease, but who have no symptoms. Butler is actively seeking volunteers in this age range who have normal memory function.

Called “the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study” – or the A4 study – the research program examines whether a new antibody treatment can slow memory loss associated with Alzheimer’s. The development of amyloid plaques in the brain has been linked to the disease.

More than 5.3 million Americans suffer from Alzheimer’s disease, and every 70 seconds, another person develops the illness. In Rhode Island, 22,000 people are currently living with Alzheimer’s.

To volunteer for the A4 study or for more information, visit www.a4study.org or contact the Butler Hospital study coordinator, Diane Monast, at 401-455-6403. •

29~11, 061614 Health Care News Briefs, 0616healthbriefs, Alzheimer’s disease, Butler Hospital, Butler Hospital, 29~11, issue061614export.pbn

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News